Technical Analysis for FOMX - Foamix Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade D 3.7 -3.39% -0.13
FOMX closed down 3.39 percent on Friday, January 18, 2019, on 36 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical FOMX trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Fell Below 20 DMA Bearish 0.00%
Jan 18 Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 16 50 DMA Resistance Bearish -4.15%
Jan 16 180 Bearish Setup Bearish Swing Setup -4.15%
Jan 15 NR7 Range Contraction -4.15%
Jan 14 Down 3 Days in a Row Weakness -1.86%
Jan 14 Down 4 Days in a Row Weakness -1.86%
Jan 14 Down 5 Days in a Row Weakness -1.86%

Older signals for FOMX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. Its lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. The company is also developing FMX101 to treat rosacea; and FDX104 to treat chemotherapy-induced rashes, as well as early-stage foam formulations of various drugs for the treatment of dermatological indications, including antibacterial drugs, antifungal drugs, corticosteroids, and immunomodulators. Foamix Pharmaceuticals Ltd. has development and license agreements Bayer AG, Merz Pharmaceuticals, LLC, Actavis plc, Prestium Pharma, Inc. and Arkin Holdings Ltd., and others. It has operations in the United States, Germany, and Israel. The company was founded in 2003 and is headquartered in Rehovot, Israel.
Is FOMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 3.21
Average Volume 538,722
200-Day Moving Average 4.9956
50-Day Moving Average 3.8964
20-Day Moving Average 3.721
10-Day Moving Average 3.897
Average True Range 0.229
ADX 14.18
+DI 16.6677
-DI 20.6693
Chandelier Exit (Long, 3 ATRs ) 3.483
Chandelier Exit (Short, 3 ATRs ) 3.897
Upper Bollinger Band 4.1879
Lower Bollinger Band 3.2541
Percent B (%b) 0.48
BandWidth 25.095404
MACD Line -0.019
MACD Signal Line -0.0337
MACD Histogram 0.0148
Fundamentals Value
Market Cap 138.47 Million
Num Shares 37.4 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -2.78
Price-to-Sales 40.32
Price-to-Book 2.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.16
Resistance 3 (R3) 4.20 4.09 4.08
Resistance 2 (R2) 4.09 3.98 4.07 4.06
Resistance 1 (R1) 3.90 3.90 3.84 3.85 4.03
Pivot Point 3.79 3.79 3.76 3.77 3.79
Support 1 (S1) 3.59 3.67 3.54 3.55 3.37
Support 2 (S2) 3.48 3.60 3.46 3.34
Support 3 (S3) 3.29 3.48 3.32
Support 4 (S4) 3.24